Lyphe Group Secures £5 Million for European Expansion

Lyphe Group, a UK-based medical cannabis ecosystem, has raised £5 million in Series A funding led by Leafy Tunnel, an early-stage venture capital fund focused on European medical cannabis and global medical psychedelics opportunities

The funding will be used by Lyphe to expand its operations across Europe with its proprietary dispensing software and vertically integrated supply chain

Lyphe Group's CEO and Co-founder, Jonathan Nadler, expressed the importance of the funding for their scale-up plans and attracting high-quality investors from the US, Europe, and UK

Bek Muslimov, Co-Founding Partner at Leafy Tunnel, highlighted the company's strong position in the market and its potential for continued growth as a leader in medical cannabis within the UK and Europe.